trial · primary record
Mosunetuzumab
Lymphoma, Follicular
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 34 |
| Primary completion | 2029-04-24 |
| Primary endpoint | Number of Participants With Complete Response (CR) as Best Response |
| Registry ID | NCT05410418 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:50.621Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05410418
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.